Non-invasive Near-infrared Spectroscopy (NIRS) Versus Invasive Licox Intracranial Pressure Monitoring in Neurocritical Care

Mayo Clinic1 site in 1 countrySeptember 1, 2021

ConditionsBrain Injuries

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Brain Injuries
Sponsor: Mayo Clinic
Locations: 1
Primary Endpoint: Correlation between changes in Licox and NIRS oxygenation measurements
Status: Withdrawn
Last Updated: 4 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

Researchers are trying to assess how accurately and safely NIRS non-invasive monitoring can detect changes in intracranial pressure to determine if this noninvasive device can be used instead of invasive monitoring with Licox in the future.

Registry

clinicaltrials.gov

Start Date

September 1, 2021

End Date

June 1, 2023

Last Updated

4 years ago

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

Mayo Clinic

Responsible Party

Principal Investigator

Alejandro Rabinstein

Principal Investigator

Mayo Clinic

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Outcomes

Primary Outcomes

Correlation between changes in Licox and NIRS oxygenation measurements

Time Frame: 3 to 5 days of the monitoring duration

Licox measures oxygenation in terms of partial pressure (PtO2) and NIRS measures it in terms of saturation (rSO2). The changes in PtO2 versus the changes in rSO2 will be compared for equivalence.